Home › Pure Autonomic Failure › Tennessee › Nashville
Pure Autonomic Failure clinical trials in Nashville, TN
8 studies for Pure Autonomic Failure are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Natural History Study of Synucleinopathies
RecruitingObservational study
- Vanderbilt Univeristy, Nashville
CPAP for the Treatment of Supine Hypertension
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
[18F]F-DOPA Imaging in Patients With Autonomic Failure
RecruitingPhase 1Healthy volunteers welcome
- Vanderbilt University Medical Center, Nashville
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Treatment of Supine Hypertension in Autonomic Failure (CPAP)
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
Recruiting
- Vanderbilt University Medical Center, Nashville
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
RecruitingPhase 1
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.